center for biologics evaluation and research
- Definition
- The FDA successor to the Bureau of Biologics concerned with biologic drugs, and most importantly, with the new protein and peptide drugs emanating from biotechnology.
- Abbreviation for
- CBER
- Broader Term
- food and drug administration
- Related Term
- center for devices and radiologic health
- center for drug evaluation and research
Send comments to info@qdossier.com Please read disclaimer before using Qsauri.